ModelEdge

InMed Pharmaceuticals Inc.
INM
Filing Type8-K
Filing Date5/18/2026
Updated5/19/26, 9:25 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD
EX-2.1AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, DATED AS OF MAY 19, 2026, BY AND AMONG INMED PHARMACEUTICALS INC., INDIGO MERGER SUB CORP., INDIGO MERGER SUB II, LLC AND MENTARI THERAPEUTICS, INC
EX-10.1FORM OF SHAREHOLDER SUPPORT AGREEMENT
EX-10.2FORM OF STOCKHOLDER SUPPORT AGREEMENT
EX-10.3FORM OF LOCK-UP AGREEMENT
EX-10.4FORM OF CVR AGREEMENT
EX-10.5FORM OF MENTARI SECURITIES PURCHASE AGREEMENT
EX-99.1Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD
EX-99.2Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD
EX-99.3Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic